Elevai Labs Inc Announces Financial Results for the Quarter Ended September 30, 2023GlobeNewsWire • 12/11/23
Elevai Labs Enters into Licensing Agreement with Yuva Biosciences to Combine Exosome and Mitochondrial Technologies to Develop New Aesthetics ProductsGlobeNewsWire • 11/29/23
U.S. IPO Weekly Recap: IPO Market Sees A Little Activity In The Short Holiday WeekSeeking Alpha • 11/26/23